TRAVERE THERAPEUTICS INC shareholder history

Current and past TRAVERE THERAPEUTICS INC shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
Context Capital Management, LLC 770.29%1.19%2.14%Q1 2022Q3 20237
CAPSTONE INVESTMENT ADVISORS, LLC 770.06%0.16%0.32%Q1 2022Q3 20237
D. E. Shaw & Co., Inc. 770.03%0.03%0.04%Q1 2022Q3 20237
CAAS CAPITAL MANAGEMENT LP 770.02%0.02%0.03%Q1 2022Q3 20237
WOLVERINE ASSET MANAGEMENT LLC 770.33%0.39%0.44%Q1 2022Q3 20237
AVIVA PLC 770.06%0.07%0.09%Q1 2022Q3 20237
HIGHBRIDGE CAPITAL MANAGEMENT LLC 770.22%0.44%0.77%Q1 2022Q3 20237
LAZARD ASSET MANAGEMENT LLC 770.02%0.03%0.04%Q1 2022Q3 20237
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 770.00%0.00%0.00%Q1 2022Q3 20237
CITIGROUP INC 770.01%0.01%0.01%Q1 2022Q3 20237
Point72 Asset Management, L.P. 330.01%0.02%0.03%Q1 2022Q3 20236
JANE STREET GROUP, LLC 510.00%0.00%0.00%Q1 2022Q3 20236
NOMURA HOLDINGS INC 660.00%0.01%0.04%Q2 2022Q3 20236
Laurion Capital Management LP 660.01%0.01%0.02%Q1 2022Q2 20236
BlackRock Inc. 660.00%0.00%0.00%Q2 2022Q3 20236
PURA VIDA INVESTMENTS, LLC 440.02%0.02%0.03%Q1 2022Q4 20224
READYSTATE ASSET MANAGEMENT LP 440.10%0.87%2.02%Q4 2022Q3 20234
Polar Asset Management Partners Inc. 440.17%0.31%0.37%Q1 2022Q4 20224
Segantii Capital Management Ltd 440.17%0.28%0.34%Q4 2022Q3 20234
BRAIDWELL LP 440.58%0.80%0.96%Q4 2022Q3 20234
LINDEN ADVISORS LP 310.01%0.14%0.30%Q1 2022Q3 20234
ABSOLUTE INVESTMENT ADVISERS, LLC 440.55%0.76%0.96%Q1 2022Q4 20224
NATIXIS 330.00%0.00%0.00%Q2 2022Q4 20223
CSS LLC/IL 210.07%0.29%0.53%Q2 2022Q1 20233
Jefferies Group LLC 330.00%0.01%0.02%Q1 2022Q3 20223
JPMORGAN CHASE & CO 330.00%0.00%0.00%Q1 2023Q3 20233
UBS OCONNOR LLC 330.41%0.55%0.64%Q1 2023Q3 20233
Perceptive Advisors 331.33%8.37%14.28%Q1 2022Q3 20223
KORNITZER CAPITAL MANAGEMENT INC /KS 330.01%0.01%0.01%Q1 2022Q3 20223
BlueCrest Capital Management Ltd 220.08%0.08%0.09%Q1 2022Q2 20222
Leucadia National 110.00%0.03%0.05%Q4 2022Q3 20232
Boussard & Gavaudan Investment Management LLP 220.38%0.48%0.57%Q3 2022Q4 20222
DeepCurrents Investment Group LLC 220.07%0.40%0.74%Q1 2022Q2 20222
MORGAN STANLEY 220.00%0.00%0.00%Q2 2023Q3 20232
III Capital Management 110.47%0.47%0.47%Q4 2022Q4 20221
FIRST HAWAIIAN BANK 110.01%0.01%0.01%Q3 2022Q3 20221
SSI INVESTMENT MANAGEMENT LLC 110.43%0.43%0.43%Q3 2022Q3 20221
SG Americas Securities, LLC 110.01%0.01%0.01%Q3 2022Q3 20221
Centiva Capital, LP 110.04%0.04%0.04%Q2 2023Q2 20231
SUSQUEHANNA INTERNATIONAL GROUP, LLP 110.00%0.00%0.00%Q1 2022Q1 20221
Worth Venture Partners, LLC 110.05%0.05%0.05%Q2 2022Q2 20221
ADVENT CAPITAL MANAGEMENT /DE/ 110.03%0.03%0.03%Q3 2022Q3 20221
Aequim Alternative Investments LP 110.08%0.08%0.08%Q2 2022Q2 20221
Wellesley Asset Management 110.11%0.11%0.11%Q1 2022Q1 20221
Lion Point Capital, LP 110.29%0.29%0.29%Q3 2023Q3 20231
SILVERBACK ASSET MANAGEMENT LLC 111.11%1.11%1.11%Q3 2023Q3 20231
Verition Fund Management LLC 110.08%0.08%0.08%Q1 2022Q1 20221
OAKTREE CAPITAL MANAGEMENT LP 110.02%0.02%0.02%Q1 2023Q1 20231
Citadel Advisors 110.00%0.00%0.00%Q1 2022Q1 20221

This page lists all the filers that currently own TRAVERE THERAPEUTICS INC or have owned TRAVERE THERAPEUTICS INC in the past.